Rating History for AbCellera Biologics (ABCL) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/29/2026 | N/A | New Coverage | Overweight (N/A) |
17.00 (N/A) |
13.92 (12.37) |
-11.14% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/29/2026 | N/A | New Coverage | Overweight (N/A) |
17.00 (N/A) |
13.92 (12.37) |
-11.14% | Details |